United Kingdom Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012

Global Markets Direct, December 2008, Pages: 120

United Kingdom Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to UK neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the neurology devices in UK

Scope

- The report provides neurology devices information broken down into detailed categories and segments in United Kingdom.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the neurology devices market in United Kingdom.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1 Table Of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 13
2.1 What Is This Report About? 13
3 Definitions of Markets Covered in the Report 14
3.1 Neurology Devices 14
3.2 CSF (Cerebro Spinal Fluid) Management 14
3.2.1 Hydrocephalus shunt 14
3.2.2 Intra Cranial Pressure (ICP) Monitors 14
3.3 Interventional Neurology 14
3.3.1 Aneurysm Clips 14
3.3.2 Embolic System 14
3.3.3 Navigational System 15
3.4 Neurostimulation Device 15
3.4.1 Spinal Cord Stimulator (SCS) 15
3.4.2 Deep Brain Stimulator (DBS) 15
3.4.3 Vagus Nerve stimulation (VNS) 15
3.5 Neurosurgical Products (Neuroendoscopes) 16
3.5.1 Neurosurgical Products (Neuroendoscopes) 16
3.6 Radio surgery 16
3.6.1 Cyber Knife Radiosurgery 16
3.6.2 Gamma Knife Radiosurgery 16
4 Healthcare Sector Review 17
4.1 Healthcare Expenditure 17
4.2 Healthcare Infrastructure 18
4.3 Healthcare Policy 20
5 Regulation System 21
5.1 Medical Equipment Approval Process 21
5.1.1 Classification of Medical Devices 21
5.1.2 Conformity Assessment Process 29
5.2 Medical Device approval fee 33
5.3 Post Market Surveillance (PMS) 34
6 Pricing and Reimbursement 35
6.1 Market Pricing 35
6.2 Government Policies for Reimbursement 35
7 Distribution Structure 37
8 Neurology Devices In United Kingdom 38
8.1 Neurology Devices Cross Country Comparison (2000-2012) 38
8.2 Neurology Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012 39
8.3 Neurology Devices, United Kingdom, Category Volume (Units), 2000-2012 43
8.4 Neurology Devices, United Kingdom Company share (2006-2007) 45
9 CSF Management In United Kingdom 46
9.1 CSF Management Overall Revenue (2000-2012) 46
9.2 CSF Management Overall Volume (2000-2012) 48
9.3 CSF Management Average Price (2000-2012) 50
9.4 CSF Management Distribution Share (2006-2007) 50
9.5 CSF Management, United Kingdom, Company Share (2006-2007) 51
10 Interventional Neurology In United Kingdom 52
10.1 Interventional Neurology Overall Revenue (2000-2012) 52
10.1.1 Embolic Systems Revenue (2000-2012) 54
10.1.2 Navigational Systems Revenue (2000-2012) 56
10.2 Interventional Neurology Overall Volume (2000-2012) 58
10.2.1 Embolic Systems Volume (2000-2012) 60
10.2.2 Navigational Systems Volume (2000-2012) 62
10.3 Interventional Neurology Average Price (2000-2012) 64
10.4 Interventional Neurology Distribution Share (2006-2007) 65
10.5 Interventional Neurology, United Kingdom, Company Share (2006-2007) 66
11 Neurostimulation Devices In United Kingdom 67
11.1 Neurostimulation Devices Overall Revenue (2000-2012) 67
11.2 Neurostimulation Devices Overall Volume (2000-2012) 69
11.3 Neurostimulation Devices Average Price (2000-2012) 71
11.4 Neurostimulation Devices Distribution Share (2006-2007) 72
11.5 Neurostimulation Devices, United Kingdom, Company Share (2006-2007) 73
12 Neurosurgical Products (Neuroendoscopes) In United Kingdom 74
12.1 Neurosurgical Products (Neuroendoscopes) Overall Revenue (2000-2012) 74
12.2 Neurosurgical Products (Neuroendoscopes) Overall Volume (2000-2012) 76
12.3 Neurosurgical Products (Neuroendoscopes) Average Price (2000-2012) 78
12.4 Neurosurgical Products (Neuroendoscopes) Distribution Share (2006-2007) 78
12.5 Neurosurgical Products (Neuroendoscopes), United Kingdom, Company Share (2006-2007) 79
13 Radiosurgery In United Kingdom 80
13.1 Radiosurgery Overall Revenue (2000-2012) 80
13.2 Radiosurgery Overall Volume (2000-2012) 82
13.3 Radiosurgery Average Price (2000-2012) 84
13.4 Radiosurgery Distribution Share (2006-2007) 84
13.5 Radiosurgery, United Kingdom, Company Share (2006-2007) 85
14 Medtronic, Inc. Company Profile 86
14.1 Company Overview 86
14.2 Value Chain Analysis 87
14.2.1 Manufacturing 87
14.2.2 Product Development 87
14.2.3 Sales and Marketing 88
14.3 Medtronic, Inc. Pipeline Products 88
14.3.1 Medtronic, Inc. Pipeline Products By Equipment Type 88
14.3.2 Medtronic, Inc. Pipeline Products By Development Stage 90
14.3.3 Medtronic, Inc. Pipeline Products By Therapy Area 91
14.3.4 Medtronic, Inc. Pipeline Products By Clinical Trials 93
14.3.5 Medtronic, Inc. Pipeline Products By News Summary 94
15 B. Braun Melsungen AG Company Profile 95
15.1 Company Overview 95
15.2 Value Chain Analysis 96
15.2.1 Manufacturing 96
15.2.2 Product Development 97
15.2.3 Sales and Marketing 98
16 Codman & Shurtleff, Inc. Company Profile 99
16.1 Company Overview 99
17 Cyberonics, Inc. Company Profile 100
17.1 Company Overview 100
17.2 Cyberonics, Inc. Pipeline Products 100
17.2.1 Cyberonics, Inc. Pipeline Products By Equipment Type 100
17.2.2 Cyberonics, Inc. Pipeline Products By Development Stage 100
17.2.3 Cyberonics, Inc. Pipeline Products By Therapy Area 100
18 Boston Scientific Corporation Company Profile 101
18.1 Company Overview 101
18.2 Value Chain Analysis 101
18.2.1 Manufacturing 102
18.2.2 Product Development 102
18.2.3 Sales and Marketing 103
18.3 Boston Scientific Corporation Pipeline Products 104
18.3.1 Boston Scientific Corporation Pipeline Products By Equipment Type 104
18.3.2 Boston Scientific Corporation Pipeline Products By Development Stage 105
18.3.3 Boston Scientific Corporation Pipeline Products By Therapy Area 106
18.3.4 Boston Scientific Corporation Pipeline Products By Clinical Trials 107
18.3.5 Boston Scientific Corporation Pipeline Products By News Summary 108
19 Maelor plc Company Profile 110
19.1 Company Overview 110
20 The Magstim Company Limited Company Profile 111
20.1 Company Overview 111
20.2 The Magstim Company Limited Pipeline Products 111
20.2.1 The Magstim Company Limited Pipeline Products By Equipment Type 111
20.2.2 The Magstim Company Limited Pipeline Products By Development Stage 111
20.2.3 The Magstim Company Limited Pipeline Products By Therapy Area 112
20.2.4 The Magstim Company Limited Pipeline Products By Clinical Trials 112
20.2.5 The Magstim Company Limited Pipeline Products By News Summary 112
21 Recent Developments 113
21.1 Product News 113
21.1.1 Dec 08, 2008: Accuray Inc. Achieves Milestone Of 150th CyberKnife System Installed 113
21.1.2 Jan 30, 2008: UK Participates In Alzheimers Disease Clinical Trial 113
22 Appendix 115
22.1 Global Markets Direct Research Methodology 115
22.2 Coverage 116
22.3 Secondary Research 116
22.4 Primary Research 117
22.5 Models 117
22.6 Forecasts 118
22.7 Expert Panels 118
22.8 Currency Conversion 119
22.9 Contact Us 120
22.10 Disclaimer 120

Executive Summary

1.2 List of Figures
Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006 18
Figure 2: Flowchart for Classification of Non-invasive Devices in UK, 2007 22
Figure 3: Flowchart for Classification of Invasive Devices in UK, 2007 23
Figure 4: Flowchart for Classification of Invasive Devices in UK, 2007 24
Figure 5: Flowchart for Classification of Invasive Devices in UK, 2007 25
Figure 6: Flowchart for Classification of Invasive Devices in UK, 2007 26
Figure 7: Flowchart for Classification of Active Devices in UK, 2007 27
Figure 8: Flowchart for Classification of Active Devices in UK, 2007 28
Figure 9: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in UK, 2007 29
Figure 10: Conformity Assessment of Class-I Medical Devices in UK, 2007 30
Figure 11: Conformity Assessment of Class-IIa Medical Devices in UK, 2007 31
Figure 12: Conformity Assessment of Class-IIb Medical Devices in UK, 2007 32
Figure 13: Conformity Assessment of Class-III Medical Devices in UK, 2007 33
Figure 14: Neurology Devices Cross Country Comparison (2000-2012) 38
Figure 15: Neurology Devices, United Kingdom, Overall Revenues ($ mn), 2000-2012 39
Figure 16: Neurology Devices, United Kingdom, Portfolio Analysis, 2000-2012 40
Figure 17: Neurology Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007 41
Figure 18: Neurology Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 42
Figure 19: Neurology Devices, United Kingdom Company share (%), 2007 45
Figure 20: CSF Management, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007 46
Figure 21: CSF Management, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012 47
Figure 22: CSF Management, United Kingdom, Overall Volume (Units), Historic, 2000-2007 48
Figure 23: CSF Management, United Kingdom, Overall Volume (Units), Forecast, 2007-2012 49
Figure 24: CSF Management, United Kingdom, Company Share (%), 2007 51
Figure 25: Interventional Neurology, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007 52
Figure 26: Interventional Neurology, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012 53
Figure 27: Embolic Systems, United Kingdom, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 54
Figure 28: Embolic Systems, United Kingdom, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 55
Figure 29: Navigational Systems, United Kingdom, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 56
Figure 30: Navigational Systems, United Kingdom, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 57
Figure 31: Interventional Neurology, United Kingdom, Overall Volume (Units), Historic, 2000-2007 58
Figure 32: Interventional Neurology, United Kingdom, Overall Volume (Units), Forecast, 2007-2012 59
Figure 33: Embolic Systems, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2007 60
Figure 34: Embolic Systems, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2007-2012 61
Figure 35: Navigational Systems, United Kingdom, Volume (Units) by Sub-Segment, Historic, 2000-2007 62
Figure 36: Navigational Systems, United Kingdom, Volume (Units) by Sub-Segment, Forecast, 2007-2012 63
Figure 37: Interventional Neurology, United Kingdom, Company Share (%), 2007 66
Figure 38: Neurostimulation Devices, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007 67
Figure 39: Neurostimulation Devices, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012 68
Figure 40: Neurostimulation Devices, United Kingdom, Overall Volume (Units), Historic, 2000-2007 69
Figure 41: Neurostimulation Devices, United Kingdom, Overall Volume (Units), Forecast, 2007-2012 70
Figure 42: Neurostimulation Devices, United Kingdom, Company Share (%), 2007 73
Figure 43: Neurosurgical Products (Neuroendoscopes), United Kingdom, Revenue ($ mn), Historic, 2000-2007 74
Figure 44: Neurosurgical Products (Neuroendoscopes), United Kingdom, Revenue ($ mn), Forecast, 2007-2012 75
Figure 45: Neurosurgical Products (Neuroendoscopes), United Kingdom, Overall Volume (Units), Historic, 2000-2007 76
Figure 46: Neurosurgical Products (Neuroendoscopes), United Kingdom, Overall Volume (Units), Forecast, 2007-2012 77
Figure 47: Neurosurgical Products (Neuroendoscopes), United Kingdom, Company Share (%), 2007 79
Figure 48: Radiosurgery, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007 80
Figure 49: Radiosurgery, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012 81
Figure 50: Radiosurgery, United Kingdom, Overall Volume (Units), Historic, 2000-2007 82
Figure 51: Radiosurgery, United Kingdom, Overall Volume (Units), Forecast, 2007-2012 83
Figure 52: Medtronic, Inc. Value Chain Analysis 87
Figure 53: B. Braun Melsungen AG Value Chain Analysis 96
Figure 54: Boston Scientific Corporation Value Chain Analysis 101
Figure 55: Global Markets Direct Methodology 115

Medtronic, Inc.
B. Braun Melsungen AG
Codman & Shurtleff, Inc.
Cyberonics, Inc.
Boston Scientific Corporation
Maelor plc
The Magstim Company Limited

Customers who bought this item also bought

• UK Electronic Cigarettes Market 2011-2015
• The UK Health and Wellness Industry Outlook to 2017 - Robust Growth in Fitness and Nutraceutical Segment
• Future Horizons in the UK Tumor Marker Testing Market: Supplier Shares and Sales Forecasts for 40 Cancer Assays by Market Segment
• United Kingdom Diagnostic Imaging Market Outlook to 2017 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others
• United Kingdom Ophthalmic Devices Market Outlook to 2017 - Vision Care, Ophthalmic Diagnostic Equipment, Cataract, Refractive, Vitreo Retinal and Glaucoma Surgery Devices
• Neurology Devices Market Outlook in United Kingdom to 2017 - Neurostimulation Devices, Interventional Neurology and Other
• The UK Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack)
• Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
• United Kingdom In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
• United Kingdom In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture